About this Course Module
This presentation has two principal objectives. First it will review
the psychobiology of the human response to stress in order to establish
the pathophysiological rationale for utilizing different classes of
medications, that act at specific pharmacological target sites, as
potential treatments for PTSD. Second it will review the current
literature on evidence-based pharmacotherapy for PTSD. New medications
currently being tested will also be discussed.
Goal: This course provides a solid background for
understanding the effects of combat stress/trauma on the human
physiological stress systems and provides an overview of pharmacological
treatments and mechanisms of action.
Objectives: After viewing the presentation, the
participant will be able to:
- Identify the major components of the human stress system
- Consider their implications in the development and treatment of PTSD and other combat-stress reactions
- Identify the major neurotransmitters and pathways (such as norepinephrine, serotonin, gaba, glutamate)
- Consider their implications in the development and treatment of PTSD
- Report the major pharmacological interventions and their likely mechanisms of action in the care of clients with PTSD/combat stress reactions
(ZIP file - 32.5 MB)
Download Transcript (PDF)
Abbreviated instructions:
- Download ZIP archive of module
- Unzip ZIP archive of module
- Double-click to open "friedman_pharmacological_a.pps" (do not move files out of folder)
Read complete instructions
(ZIP file - 2.7 MB)
Download Transcript (PDF)
Abbreviated instructions:
- Download ZIP archive of module
- Unzip ZIP archive of module
- Double-click to open "friedman_pharmacological.pps"
Read complete instructions
How to obtain Continuing Education Credits
Continuing education credits can be earned for this course. For more information and step-by-step instructions, please visit the CE Credits page. Here is the brochure required for CEs for this course.
